好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuromyeltis Optica Spectrum Disorder Disease Activity in the Nonagenarians: Recalcitrant Autoimmunity Unabated by Aging
Autoimmune Neurology
P12 - Poster Session 12 (11:45 AM-12:45 PM)
8-011
NA

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune, inflammatory disorder of the CNS characterized by longitudinally extensive myelitis (LETM) in the spinal cord and optic nerves in most cases. NMOSD typically occurs in females (80%) between the ages 30-40.  However, late-onset NMOSD has been reported in octogenarians (80-82) and one case report of a 90-year-old women.  Herein, we report another case of elderly-onset NMOSD presenting with LETM, initially thought to be due to spinal cord infarct, but further workup revealing a late manifestation of the disease.   

NA

A 93-year-old African American woman presented with left leg weakness progressing over 3 days to bilateral involvement and sensory deficits.  MRI of the thoracic spine showed abnormal T2/STIR intramedullary hyperintensity from C7-T6.  On the sagittal thoracic diffusion sequences, there was restriction observed. CT Angio (CTA) revealed a severely calcified thoracic aorta without any evidence of dissection.  The small branch vessels supplying the spinal cord were not conclusively identified and intercostal vessels to the upper thoracic spine levels demonstrated diminished to absent opacification. Based on CTA findings, spinal cord ischemia was initially suspected, however, the progressive course over several days and CSF pleocytosis suggested an inflammatory process.  Serum anti-AQP4 anybody titers were high at 1: 100,000. The patient received 5 days of intravenous methylprednisolone and plasma exchange, but of little benefit. Given the age and co-morbidities, she was treated conservatively without any disease modifying therapy. Patient died due to the complications of NMOSD.  

The case highlights the importance of testing for NMOSD antibody in the elderly regardless of age and vascular comorbidities. Acute treatment in late-onset NMOSD is less efficacious. Aging is associated with immune dysfunction in Th17 cells (increased number), increased permeability of BBB, accumulation of atypical B cells, and complement dysfunction, which could increase the risk of NMOSD relapses into senectitude.  

Authors/Disclosures
Melissa Bendayan, MD (University of Chicago Medicine)
PRESENTER
Dr. Bendayan has nothing to disclose.
Alejandra Duque Ramirez, MD (University of Chicago) Dr. Duque Ramirez has nothing to disclose.
Josephe Archie Honorat, MD, PhD Dr. Honorat has nothing to disclose.
Amy Espinal, MD (The University of Chicago) Dr. Espinal has nothing to disclose.
Okker Verhagen Metman, DO (University of Chicago) Dr. Verhagen Metman has nothing to disclose.
Helene Rubeiz, MD (University of Chicago Medicine) Dr. Rubeiz has nothing to disclose.
Amanda F. Abuaf, MD (University of Wisconsin) Dr. Abuaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Adil Javed, MD, PhD (University of Chicago) The institution of Dr. Javed has received research support from Genentech Roche .